Inventurus Knowledge Solutions Limited has informed the Exchange about Transcript of Conference Call IKS - Partnership with and Investment in WWMG .This is in reference to our letter dated June 30, 2025, regarding the schedule of the Conference Call, and our letter dated July 3, 2025, regarding the submission of the presentation and audio recording of the said Conference Call.Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the transcript of the conference call held on Thursday, July 3, 2025, for the IKS - Partnership with and Investment in WWMG .The said transcript has also been uploaded on the Company s website and can be accessed through the following link:https://ikshealth.com/ir/sebi-disclosures/conference-call-transcript-IKS-Partnership-with-and-Investment-in-WWMG-Jul03-2025.pdf

IKS announced a $17 million investment in a newly formed MSO entity co-owned with Western Washington Medical Group (WWMG), a ~$100 million revenue, 100-clinician group based in Washington State. At a pre-money valuation of $18.4 million, IKS will hold 48% while WWMG physicians hold 52%, with no physician cash-outs—all capital is directed toward physician growth. The MSO will provide all non-clinical services (back office, front office, IT, payroll) to WWMG under a 30-year contract, while IKS deploys its full Care Enablement Platform. Management indicated the platform typically generates 10-12% of customer revenue and delivers 850-1,200 bps of EBITDA expansion for provider clients, with the MSO investment expected to deliver ROE north of 20%. This is IKS's second large strategic deal after Palomar Health ($16.5M) and is part of its 'IKS 3.0' strategy of taking upstream ownership in provider aggregations. CFO noted current leverage is 0.5-0.6x EBITDA, down from a peak of $117 million, and the company remains committed to non-dilutive, conservative capital deployment.